Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amorphous oxide--a platform for drug delivery.

Chun-Ming Shih1, Shing-Jong Lin, Yea-Yang Su

  • 1Graduate Institute of Medical Sciences, School of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|February 1, 2005
PubMed
Summary

This study explores using an oxide layer as a polymer-free drug-loading platform for medical devices, like cardiovascular stents. Results show amorphous oxide effectively replaces polymer coatings, reducing risks such as inflammation and thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wearable IoT health sensing beyond functional utility: Identity-expressive and hedonic determinants of user acceptance in intimate physiological monitoring devices - A sequential FA-ANP mixed-methods investigation with digital health policy implications.

Digital health·2026
Same author

Taiwan Association of Thoracic and Cardiovascular Surgery (TATCS) Position Statement: Surgeon's Role in the Present Era of Isolated Severe Aortic Stenosis Patient Management.

Acta Cardiologica Sinica·2026
Same author

Impact of stent materials and hemodynamic changes after endovascular aneurysm repair for abdominal aortic aneurysm.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Response to "Febuxostat and cardiovascular outcomes: Methodological considerations and future directions".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice.

Pharmaceutical research·2026
Same author

Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection.

Journal of nanobiotechnology·2026

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Surface Chemistry

Background:

  • Polymer coatings on metallic medical devices can cause adverse effects like thrombosis and inflammation post-implantation.
  • Current drug-eluting stent technology relies on polymer coatings for drug delivery.

Purpose of the Study:

  • To investigate the potential of an amorphous oxide layer as a polymer-free platform for drug loading on cardiovascular stents.
  • To evaluate the efficacy of an oxide layer as a substitute for polymer coatings in drug delivery systems.

Main Methods:

  • Experimental studies involving cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and electron spectroscopy for chemical analysis (ESCA).
  • High-performance liquid chromatography (HPLC) and activated clotting time (ACT) assays were used to confirm drug loading and elution.

Related Experiment Videos

  • Amorphous oxide film on 316LVM stainless steel wire was utilized for heparin loading and elution studies.
  • Main Results:

    • Successful loading and elution of heparin onto the amorphous oxide film were confirmed.
    • The amorphous oxide layer demonstrated potential for drug delivery applications.
    • Experimental data validated the feasibility of using oxide films for drug carriage.

    Conclusions:

    • Amorphous oxide layers can serve as an effective polymer-free alternative for drug loading on medical devices, particularly cardiovascular stents.
    • This approach shows promise in minimizing risks associated with polymer coatings, including metallic corrosion, inflammation, late-thrombosis, and restenosis.
    • The findings suggest a new direction for developing safer and more effective drug-eluting stents.